NASDAQ:TRIL
Delisted
Trillium Therapeutics Inc. Stock News
$18.44
+0 (+0%)
At Close: May 27, 2022
Trillium (TRIL) to be Acquired by Pfizer for $2.3 Billion
01:45pm, Tuesday, 24'th Aug 2021
Trillium (TRIL) is set to be acquired by Pfizer for $2.3 billion or $18.50 per share. Stock shoots up.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Trillium Therapeutics Inc. (NASDAQ: TRIL) to Pfizer Inc. for $18.50 per share in ca
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News
12:59pm, Tuesday, 24'th Aug 2021
The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.
Pfizer To Buy Cancer Biotech Company Trillium For $2.3 Million
09:00pm, Monday, 23'rd Aug 2021
What do you do when you're brimming with billions of dollars in new vaccine revenue? You splurge, of course!
What Did the Stock Market Do Today, Aug. 23? 3 Big Stories to Catch Up On.
05:04pm, Monday, 23'rd Aug 2021
So what did the stock market do today? Investors cheered on Pfizer stock and rallied behind infrastructure plays.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Trillium Therapeutics Inc. (NASDAQ: TRIL) to Pfizer Inc. for $18.50 per share in ca
TRIL Stock: The Huge $2.3B Deal Sending Trillium Therapeutics Up 200%
10:56am, Monday, 23'rd Aug 2021
TRIL stock is soaring to nearly triple its Friday prices. Pfizer is acquiring the oncology company in a multi-billion dollar deal.
Pfizer to buy cancer drug maker Trillium for $2.3B
10:29am, Monday, 23'rd Aug 2021
Pfizer said it will pay $18.50 a share for the Cambridge, Massachusetts-based drug maker Trillium.
Why Trillium Therapeutics Stock Is Skyrocketing Today
09:39am, Monday, 23'rd Aug 2021
Pfizer may have gotten a fantastic deal on this clinical-stage oncology company.
Trillium Therapeutics Shares Increase Over 190% Pre-Market: Why It Happened
07:52am, Monday, 23'rd Aug 2021
The shares of Trillium Therapeutics Inc (NASDAQ: TRIL) increased by over 190% pre-market. This is why it happened.
Trillium Therapeutics shares soar on Pfizer's $2.26B deal
07:26am, Monday, 23'rd Aug 2021
Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
Trillium Therapeutics' stock nearly triples after buyout deal with Pfizer valued at $2.26 billion
07:04am, Monday, 23'rd Aug 2021
Shares of Trillium Therapeutics Inc. TRIL, +3.92% nearly tripled in premarket trading Monday, skyrocketing 189.3%, after the immuno-oncology company announced an agreement to be acquired by Pfizer Inc
Pfizer to Acquire Trillium Therapeutics Inc.
06:45am, Monday, 23'rd Aug 2021
Proposed acquisition strengthens Pfizer's category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for hematological malignancies
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
07:00am, Friday, 13'th Aug 2021
CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer
CAMBRIDGE, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer,
